Familial hyperlipidemia: Resolving a case using evidence-based medicine

Background: familial hypercholesterolemia (FH) and familial hyperlipidemia combined (HFC) are metabolic disorders of lipids associated with increase of the risk for cerebrovascular disease. Clinical case: 8-years-old Indigenous child with HFC presented right hemiparesis, motor aphasia and right cent...

Full description

Bibliographic Details
Main Authors: Edison Benavides-Hernández, Alexander Burbano-Imbachí, Hernando Almonacid-Córdoba, Cristina Collazos-Cerón, Victor Castro-Cruz, Álvaro Bastidas-Velasco, Andrea salas-Mesías, Jaime Bonilla-Medina, Álvaro Narváez-Gómez, Mario Delgado-Noguera
Format: Article
Language:Spanish
Published: Universidad del Cauca 2011-03-01
Series:Revista de la Facultad de Ciencias de la Salud
Subjects:
Online Access:http://revistas.unicauca.edu.co/index.php/rfcs/article/view/81
Description
Summary:Background: familial hypercholesterolemia (FH) and familial hyperlipidemia combined (HFC) are metabolic disorders of lipids associated with increase of the risk for cerebrovascular disease. Clinical case: 8-years-old Indigenous child with HFC presented right hemiparesis, motor aphasia and right central facial paralysis for a cerebral ischemic accident; in addition, he had altered lipid profile and family history of hypercholesterolemia. Methodology: this article used patient`s therapeutic approach using evidence-based medicine (EBM), started from a structured clinical question and PubMED search. Four systematic reviews were included. Discussion: statins are safe in children with HF and HFC are effective in improving lipid profile. EBM methodology could help to solve similar therapeutic problems.
ISSN:0124-308X
2538-9971